ODTX
Odyssey Therapeutics, Inc.Company Information
- Company Name
- Odyssey Therapeutics, Inc.
- CIK
- CIK0001882782
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- ODTX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- ODTX
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-11
- Last sale
- 2026-05-11
- Shares purchased (TTM)
- 4,183,777
- Shares sold (TTM)
- 1,780
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 34,400,969
- Shares outstanding
- 30,277,051
- Ownership
- 113.62%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 13.04%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|
| Series A Preferred Stock | 0 | 0 | ||||||
| Series B Preferred Stock | 0 | 0 | ||||||
| Series C Preferred Stock | 0 | 0 | ||||||
| Series D Preferred Stock | 0 | 0 | ||||||
Assets Current | ||||||||
| Cash And Cash Equivalents At Carrying Value | 82 | 36 | ||||||
| Marketable Securities Current | 229 | 140 | ||||||
| Prepaid Expense And Other Assets Current | 11 | 9 | ||||||
| Assets Current | 321 | 185 | ||||||
| Property Plant And Equipment Net | 5 | 7 | ||||||
| Operating Lease Right Of Use Asset | 17 | 18 | ||||||
| Goodwill | 14 | 14 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | ||||||
| Marketable Securities Noncurrent | 122 | 0 | ||||||
| Other Assets Noncurrent | 4 | 5 | ||||||
| Assets | 484 | 229 | ||||||
Liabilities Current | ||||||||
| Accounts Payable Current | 8 | 8 | ||||||
| Accrued Liabilities Current | 15 | 9 | ||||||
| Operating Lease Liability Current | 5 | 5 | ||||||
| Liabilities Current | 28 | 22 | ||||||
| Operating Lease Liability Noncurrent | 19 | 21 | ||||||
| Liabilities | 63 | 49 | ||||||
| Redeemable Noncontrolling Interest Equity Preferred Carrying Amount | - | 704 | ||||||
Stockholders Equity | ||||||||
| Common Stock Value | 0 | 0 | ||||||
| Preferred Stock Value | 0 | - | ||||||
| Additional Paid In Capital | 1,081 | 83 | ||||||
| Retained Earnings Accumulated Deficit | -659 | -606 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -0 | ||||||
| Stockholders Equity | 421 | -524 | ||||||
| Liabilities And Stockholders Equity | 484 | 229 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 365 | ||||||
| Common Stock Shares Issued | 48 | 3 | ||||||
| Shares Outstanding | 48 | 2 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 50 | - | ||||||
| Preferred Stock Shares Issued | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialOdyssey Therapeutics, Inc. (ODTX) — SEC Financial Statements & Analysis
Odyssey Therapeutics, Inc. (ODTX) is a biological products, (no diagnostic substances) company, incorporated in DE. Odyssey Therapeutics, Inc. trades on Nasdaq as: ODTX. Odyssey Therapeutics, Inc. (ODTX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Odyssey Therapeutics, Inc. carries a market cap of $566.48M, a P/B ratio of 1.34x, and an enterprise value of $481.00M. On the balance sheet, it maintains a current ratio of 11.36x, a quick ratio of 10.98x, working capital of $293.17M, a debt-to-equity ratio of 0.15x, a debt ratio of 0.13, and net debt of $-85.48M. Figures sourced from SEC EDGAR.
- Market Cap
- $566.48M
- P/B TTM
- 1.34x
- Debt To Equity
- 0.15x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Odyssey Therapeutics, Inc. in?
Odyssey Therapeutics, Inc. (ODTX) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does ODTX trade on?
Odyssey Therapeutics, Inc. (ODTX) trades on the Nasdaq.
Where is Odyssey Therapeutics, Inc. incorporated?
Odyssey Therapeutics, Inc. is incorporated in DE.
When was Odyssey Therapeutics, Inc. (ODTX)'s most recent SEC filing?
Odyssey Therapeutics, Inc. (ODTX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is ODTX's market cap?
Odyssey Therapeutics, Inc. (ODTX) has a market capitalization of $566.48M as of 2026-06-30.